Cryoport (CYRX) - Utang marang Ekuitas

Serving as the primary valuation tool, this Cryoport, Inc. (CYRX) price chart demonstrates the financial standing of a monopolist in the live cell transport niche, whose indicator stands at 0.49. The business relies on partnerships with genetic laboratories to create ultra-low temperature freezing systems. The company's stability is based on its independence from economic cycles, although revenues depend on funding within the biotechnology sector.

This ratio measures the proportion of borrowed funds relative to equity, determining the level of financial risk. Analyzing the debt leverage history of Cryoport, Inc. allows for an assessment of the balance sheet structure's resilience to interest rate changes. The metric is calculated as the ratio of total liabilities to net assets. For Cryoport, Inc., moderate leverage is justified by the high margins of its unique logistics services. The ability to exercise pricing power in biopharmaceuticals ensures reliable debt service.